Commentary

Department of Neurology, Division of Neurocritical Care, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, Saint Louis, Missouri. 63110, USA, dharr@neuro.wustl.edu

Address for correspondence: Dr. Rajat Dhar Campus Box 8111, 660 S Euclid Ave Saint Louis Missouri 63110 USA dharr@neuro.wustl.edu

Journal of Neurosciences in Rural Practice

Licence

This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.

Conflicts of interest

None

REFERENCES

Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, Tsugane R, . Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: Serial magnetic resonance imaging. Neurosurgery. 2001;49:1341-8.
[Google Scholar]
Rabinstein A. A., Weigand S, Atkinson JL D, Wijdicks E. F., . Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2005;36:992-7.
[Google Scholar]
Rosengart A. J., Schultheiss K. E., Tolentino J, Macdonald R. L., . Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:2315-21.
[Google Scholar]
Weir B, Grace M, Hansen J, Rothberg C, . Time course of vasospasm in man. J Neurosurg. 1978;48:173-8.
[Google Scholar]
Fisher C. M., Roberson G. H., Ojemann R. G., . Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations. Neurosurgery. 1977;1:245-8.
[Google Scholar]
Rabinstein A. A., Friedman J. A., Weigand S. D., Robyn L, Fulgham J. R., Manno E. M., et al. . Predictors of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage. Stroke. 2004;35:1862-6.
[Google Scholar]
Pluta R. M., Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald R. L., Nishizawa S, et al. . Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res. 2009;31:151-8.
[Google Scholar]
Macdonald R. L., Higashida R. T., Keller E, Mayer S. A., Molyneux A, Raabe A, et al. . Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) Lancet Neurol. 2011;10:618-25.
[Google Scholar]
Salunke P, Gupta S. K., . Symptomatic Bilateral Isolated Perforator vasospasm following aneurysmal subarachnoid Haemorrhage. J Neurosci Rural Pract. 2013;1:45-47.
[Google Scholar]
Dhar R, Scalfani M. T., Blackburn S, Zazulia A. R., Videen T, Diringer M, . Relationship Between Angiographic Vasospasm and Regional Hypoperfusion in Aneurysmal Subarachnoid Hemorrhage. Stroke. 2012;43:1788-94.
[Google Scholar]
Dankbaar J. W., Slooter A. J., Rinkel G. J., Schaaf I. C., . Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: A systematic review. Crit Care. 2010;14:R23.
[Google Scholar]

Fulltext Views
24

PDF downloads
0

View/Download PDF
Download Citations

BibTeX
RIS

Show Sections

Commentary

Conflicts of interest

REFERENCES

Suggested read for related articles: